Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER has issued a Tender notice for the procurement of a Construction and Operation of a Medication Management Application for the Specific Clinical Research “Researcher-Initiated Open-Label Study to Evaluate the Safety and Tolerability of Pahr-120 in Patients with Pulmonary Arterial Hypertension (Pah)”... in the Japan. This Tender notice was published on 16 May 2026 and is scheduled to close on 30 May 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 141394833, while the tender notice number is and Registering on the platform.
Procurement Summary
Country: Japan
Summary: Construction and Operation of a Medication Management Application for the Specific Clinical Research “Researcher-Initiated Open-Label Study to Evaluate the Safety and Tolerability of Pahr-120 in Patients with Pulmonary Arterial Hypertension (Pah)”...
Deadline: 30 May 2026
Posting Date: 16 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141394833
Document Ref. No.:
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details Tender Details Construction and operation of a medication management application for the specific clinical research “Researcher-initiated open-label study to evaluate the safety and tolerability of PAHR-120 in patients with pulmonary arterial hypertension (PAH)” Tender announcement regarding the contract Description: Complete set of medication management application construction and operation work for specific clinical research “Researcher-initiated open-label study to evaluate the safety and tolerability of PAHR-120 in patients with pulmonary arterial hypertension (PAH).” Deadline: 2026-05-30 [Disclaimer: This notice does not specify a specific deadline, so we have added 15 days from the date of posting] Documents
Procurement Documents for Japan
Access a comprehensive library of standard procurement documents specific to Japan. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Japan
Want To Bid in This Tender?
Get Local Agent Support in Japan and 60 More Countries.
View Tenders By
Sign in with Google